Skip to main content
. 2016 Dec 13;11(12):e0167641. doi: 10.1371/journal.pone.0167641

Fig 3. Genomic landscape of the Korean patients.

Fig 3

(A) Frequency of gene mutations broken down by CLL stage. (B) Number of mutations according to the Binet stage. (C) Number of mutation sites in each gene that occur in more than 5% of the population.